MeMaLoc: Magnetic Marker Localization for Melanoma Surgery. A feasibility study.

• Conditions: melanoma; skin cancer; 10027655; 10040900; 10040795

• Registration Number: NL-OMON42850
• Lead Sponsor: ederlands Kanker Instituut

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1. 18 years or older
2. Signed informed consent
3. Scheduled for either
* Surgery of clinically occult (sub)cutaneous or muscular melanoma lesion(s) (group 1)
OR
* Complete Lymph Node Dissection of inguinal or axillary region (group 2)

Exclusion Criteria

- MRI necessary in period between placement of magnetic marker and surgery

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>1. Retrieval rate: in how many cases is the surgeon able to adequately localise<br /><br>and remove the marked lesion using the magnetic detection technology.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>2. Radiologist satisfaction: to what extent is placing the experimental<br /><br>magnetic marker comparable to the current clinical practice, what is different<br /><br>and what are (dis)advantages?<br /><br>3. Surgeon satisfaction: how does intraoperative localisation using the<br /><br>magnetic technology compare to the current clinical practice, what is different<br /><br>and what are (dis)advantages?</p><br>